Occupational Therapists in West Jordan, UT Accepting Medicare

6 Occupational Therapists found. Showing 1 - 6

Destiny A Robles, MOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7733 S Redwood Rd, West Jordan, UT 84084 Phone: 801-885-1700

Rebecca Vasta, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7733 S Redwood Rd, West Jordan, UT 84084 Phone: 801-885-1700

Cheryl Woodard, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3590 W 9000 S, West Jordan, UT 84088 Phone: 801-601-2320

Savannah Slater, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1227 W 9000 S Ste B, West Jordan, UT 84088 Phone: 801-942-3311

Shelby Ivory Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3580 W 9000 S, C/o Jordan Valley Medical Center, West Jordan, UT 84088 Phone: 801-561-8888    Fax: 801-569-8723

Deanna Mackay-clark, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 9301 South Wights Fort Rd, Suite 215, West Jordan, UT 84088 Phone: 801-282-2200    Fax: 801-282-2220

News Archive

Researchers identify promising combination strategy for treating glioblastomas

Therapies that specifically target mutations in a person's cancer have been much-heralded in recent years, yet cancer cells often find a way around them. To address this, researchers at University of California, San Diego School of Medicine and Moores Cancer Center identified a promising combinatorial approach to treating glioblastomas, the most common form of primary brain cancer.

Standard formula for calculating LDL cholesterol levels is often inaccurate, study finds

In what promises to be an eye-opener for many doctors and patients who routinely depend on cholesterol testing, a study led by researchers at the Johns Hopkins University School of Medicine found that the standard formula used for decades to calculate low-density lipoprotein cholesterol levels is often inaccurate.

Structure of monoclonal antibody that can potently neutralize SARS-CoV-2 and variants of concern

A new preprint deals with the analysis of the monoclonal antibody J08, which was capable of powerful neutralization of the wildtype SARS-CoV-2, and its VOCs.

NIH funds collaborative project to develop better vaccine adjuvants for many diseases

Dr. Qizhi Cathy Yao, professor of surgery, molecular virology and microbiology, and pathology & immunology at Baylor College of Medicine, has been awarded a National Institutes of Health grant to fund a collaborative project with Molecular Express, Inc.

Adynovate approved for patients with Hemophilia A

The U.S. Food and Drug Administration today approved Adynovate, Antihemophilic Factor (Recombinant), PEGylated for use in adults and adolescents, aged 12 years and older, who have Hemophilia A. Adynovate is modified to last longer in the blood and potentially require less frequent injections than unmodified Antihemophilic Factor when used to reduce the frequency of bleeding.

Read more Medical News

› Verified 2 days ago